Heart Disease Trial, Recruiting (NCT06535503)

Heart Disease Trial, Recruiting NCT06535503 Sponsor: Abu Dhabi Health Services Company Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06535503 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older.
People who had a specific type of heart attack (called STEMI) that was complicated by a serious condition where the heart could not pump enough blood (called cardiogenic shock).
People who were hospitalised or treated at SSMC or SKMC for this type of heart attack complicated by cardiogenic shock.
People who were admitted to hospital between January 2019 and March 2024.

Who may not be able to join:

People under the age of 18.
People who experienced the serious low blood pumping condition (cardiogenic shock) for a reason other than a heart attack.
People whose cardiogenic shock was related to a different type of heart attack (called NSTEMI rather than STEMI).
People who were not treated at SSMC or SKMC for their STEMI complicated by cardiogenic shock.
People who were not admitted to hospital within the period of January 2019 to March 2024.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Abdulmajeed BS Alzubaidi, MD, Abu Dhabi Health Services Co. -SEHA

Phone: 0097124102534

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06535503

Sponsor: Abu Dhabi Health Services Company

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 0097124102534

More information: https://clinicaltrials.gov/study/NCT06535503

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older.
People who had a specific type of heart attack (called STEMI) that was complicated by a serious condition where the heart could not pump enough blood (called cardiogenic shock).
People who were hospitalised or treated at SSMC or SKMC for this type of heart attack complicated by cardiogenic shock.
People who were admitted to hospital between January 2019 and March 2024.

Who may not be able to join:

People under the age of 18.
People who experienced the serious low blood pumping condition (cardiogenic shock) for a reason other than a heart attack.
People whose cardiogenic shock was related to a different type of heart attack (called NSTEMI rather than STEMI).
People who were not treated at SSMC or SKMC for their STEMI complicated by cardiogenic shock.
People who were not admitted to hospital within the period of January 2019 to March 2024.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Abu Dhabi Health Services Company

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

1 January 2025

Where this trial is recruiting

🇦🇪 United Arab Emirates

Primary endpoints

Analyze STEMI patient with CS disease profile; Incidence of CS-complicated AMI events; Analyze treatment outcomes in the targeted population as per the patient profile; Analyze STEMI patient with CS disease profile; Analyze treatment outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov